Synergy CHC (SNYR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for June 18, 2025, to be held virtually at 10:00 a.m. Eastern Time.
Shareholders can access proxy materials online or request paper/email copies by June 4, 2025.
Voting is available electronically, by mail, or in person (virtually) with advance registration.
Voting matters and shareholder proposals
Election of five directors for one-year terms expiring in 2026.
Ratification of RBSM LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.
Approval to amend the 2024 Equity Incentive Plan, increasing shares available for issuance to 2,252,102.
Approval to amend Articles of Incorporation to authorize up to 1,000,000 shares of preferred stock.
Board recommends voting "FOR" all director nominees and proposals.
Board of directors and corporate governance
Director nominees: Jack Ross, Alfred Baumeler, J. Paul SoRelle, Nitin Kaushal, and Scott Woodburn.
All nominees are recommended by the Board for election.
Latest events from Synergy CHC
- Q3 sales fell on rebranding, but profitability, liquidity, and growth plans remain strong.SNYR
Q3 202411 Jan 2026 - All director nominees and key proposals were approved, with results to be filed with the SEC.SNYR
AGM 20256 Jan 2026 - Profitability maintained amid revenue decline; IPO and new launches set stage for 2025 growth.SNYR
Q4 202426 Dec 2025 - Shelf registration for $100M in securities, with $5.69M ATM offering to fund growth and expansion.SNYR
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Stockholders to vote on director elections, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Health and wellness firm targets Nasdaq IPO to fund growth amid strong 2023 results and high debt.SNYR
Registration Filing30 Nov 2025 - Consumer health company targets Nasdaq IPO to fund growth amid high debt and concentrated sales.SNYR
Registration Filing30 Nov 2025 - IPO aims to fund brand growth and expansion amid recent financial improvement and high leverage.SNYR
Registration Filing30 Nov 2025